GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
The landscape of diabetes and obesity management made a significant transformation in 2026, driven by the development of oral glucagon-like peptide-1 (GLP-1) receptor agonists. That means the idea of popular weight loss drugs, like tirzepatide and semaglutide, are now easier to swallow literally, figuratively, and financially. Traditionally administered via injection, GLP-1 therapies are now being formulated into pill forms, promising greater accessibility and adherence for p
We keep hearing that GLP-1s are changing the way Americans eat, but most coverage still treats the average user like a faceless calorie counter. That’s not the story. New research from IFF breaks down the GLP-1 diet trends.
Here’s a riddle: What makes so much noise in your head that it controls every step you take—yet you don’t actually hear it until it’s gone? The buzzword is "food noise," and if you're taking GLP-1s like Ozempic, Wegovy, Zepbound, or Mounjaro, you're likely feeling very seen right now. But what is food noise, really?
